跳至主要内容
临床试验/CTRI/2026/01/100903
CTRI/2026/01/100903尚未招募不适用

To study the prevalence of Blood group antigens in tribal populations of coastal Karnataka: an observational study

QuidelOrtho India1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2026年1月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
204
试验地点
1

研究概览

简要总结

Blood group antigens play an important role in compatibility testing, yet data on their prevalence among Indian Tribal communities is limited. This study seeks to establish ABO, Rh, Kell, Duffy, Kidd, Lewis, MNSs antigen prevalence in Koraga tribe and compare it to established data among non-tribal populations of Coastal Karnataka. This study also seeks to assess the knowledge, attitude and practice towards blood donations to identify gaps in awareness, trends in attitude and thus help inform tailored education and awareness strategies. Study will be conducted under the guidance of Centre of Indigenous Population, after obtaining permission from appropriate authorities. Adults from tribal hamlets will be enrolled during health camps after obtaining informed consent relevant to vulnerable populations in accordance with the guidelines laid down in the Declaration of Helsinki. Structured and validated KAP questionnaire will be used to collect data before and after providing education regarding blood donation. EDTA Blood samples collected will be tested with commercially available antisera against Blood group antigens. Data compilation will be done in Microsoft Excel and Analysis via SPSS. Study Findings will help determine the suitability of non-tribal donor pools for meeting the tribe’s transfusion needs, support rare donor registry contributions, and improve transfusion safety through education and extended antigen phenotyping. Improved knowledge and positive attitude shifts toward blood donation may foster sustainable engagement with transfusion services and contribute to better healthcare outcomes in this vulnerable community.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Adults (age over 18 yrs) from tribal hamlets of coastal Karnataka (Koraga) who consent to participate in the study.

排除标准

  • Any individuals with history of recent blood transfusion (last 3 months) or transplant (Hematopoietic stem cell transplant (HSCT)/Bone marrow transplant (BMT)).

研究者

发起方
QuidelOrtho India
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Ojasvi Manchanda

KMC, Manipal

研究点 (1)

Loading locations...

相似试验